Plus   Neg

BioPharmX: Phase 2b Trial Of BPX-04 Meets Primary, Secondary Endpoints

BioPharmX Corp. (BPMX), a specialty pharmaceutical company focused on medical dermatology products, announced Tuesday positive results from its Phase 2b clinical trial of BPX-04 for papulopustular rosacea.

In pre-market activity, BioPharmX shares were gaining around 62 percent to trade at $1.43.

BPX-04 is a novel topical gel formulation of fully solubilized minocycline for the treatment of moderate-to-severe papulopustular rosacea.

The randomized, double-blind, vehicle-controlled Phase 2b trial enrolled 206 subjects aged 18 years and above with moderate-to-severe papulopustular rosacea. The study evaluated the safety and efficacy of once daily application of BPX-04, versus a vehicle control over a 12-week treatment period.

The company noted that BPX-04, a 1% minocycline gel, successfully met both the primary and secondary endpoints of the trial. It demonstrated a statistically significant mean change in the number of facial inflammatory lesions and a two-grade improvement to clear or almost clear on the Investigator's Global Assessment or IGA scale from baseline to week 12.

David Tierney, BioPharmX CEO, said, "Based on the efficacy and safety profile, we believe BPX-04 has the potential to be the best-in-class treatment for papulopustular rosacea."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. (TM) announced plans to invest $391 million at its pickup truck assembly plant in San Antonio, Texas. The investment is part of the Japanese automaker's plan to invest $13 billion in its U.S. operations over five years through 2021. The company said the investment will be used... Virgin Atlantic is set to challenge British Airways' dominance at London Heathrow as the carrier announced plans to fly to 84 new destinations from the airport when its third runway is opened. Chief Executive Shai Weiss said, "Heathrow has been dominated by one airline group for far too long. The... Walmart (WMT) on Wednesday announced that it is teaming up with Capital One to roll out two new credit cards designed to compete with cards from Apple and Amazon. The companies said the Capital One Walmart Rewards Credit Card Program with two new cards will launch on September 24. The program's Mastercard...
Follow RTT